ARCHIVES

Cancer Control Contract Negotiations To Start Soon; Two Weaknesses Occur In Many Proposals

This article is from The Cancer Letter archive.

Vol. 01 No. 10 | March 7, 1975

Download PDF Visit The Full Archive

Related Articles

Cancer Webmasters Seek to Develop Tools for Greater Use of NCI Cancer Information

May 5, 2000

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

NIH News: NTP To test Herbs for Toxicity

August 13, 1999

In Brief: Carbone To Leave NCI for Wisconsin ACS’ Holleb Says Tobacco Industry Tries to Hide Ad Warning

October 3, 1975

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979